GB210 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role of gp210 Antibody

gp210 is a 209 kDa transmembrane glycoprotein located in the nuclear pore complex . Anti-gp210 IgG antibodies are disease-specific antinuclear antibodies (ANAs) that serve as biomarkers for PBC, particularly in patients negative for antimitochondrial antibodies (AMA) . These antibodies are highly specific (>98%) but exhibit low sensitivity (~25%) for PBC .

Diagnostic Relevance

  • AMA-Negative PBC: Anti-gp210 antibodies aid in diagnosing PBC in ~30% of AMA-negative patients .

  • Diagnostic Criteria: The presence of anti-gp210 antibodies, alongside elevated alkaline phosphatase (ALP) and histologic evidence, confirms PBC .

Table 1: Diagnostic Thresholds for Anti-gp210 Antibody

Anti-gp210 IgG Level (Units)Interpretation
≤20.1Negative
20.1–24.9Equivocal
≥25.0Positive

Prognostic Value

Anti-gp210 positivity correlates with aggressive disease progression and poor outcomes:

  • Liver Failure: 5.77-fold higher risk (95% CI: 2.9–11.48) .

  • Mortality: 2.38-fold increased risk of death or liver transplantation .

  • Treatment Response: 39.3% of anti-gp210-positive patients fail ursodeoxycholic acid (UDCA) therapy vs. 16.7% in negative cohorts .

Table 2: Prognostic Outcomes in Anti-gp210-Positive PBC

ParameterAnti-gp210 (+)Anti-gp210 (−)
5-Year Transplant-Free Survival77.0%90.3%
Liver-Related Mortality22.0%9.2%
Histologic Severity*HigherLower

*Includes lobular inflammation, interfacial hepatitis, and bile duct injury .

Mechanistic Insights

  • Pathogenesis: Molecular mimicry triggered by bacterial or endogenous peptides may drive anti-gp210 production .

  • Immune Response: T cells and cytokines (e.g., IL-12, IFN-γ) contribute to gp210 antigen presentation and antibody generation .

Diagnostic Methodology

Anti-gp210 antibodies are detected via semi-quantitative ELISA, with results reported in 1–8 days . Notably, HEp-2 indirect immunofluorescence (IFA) is unreliable for gp210 detection, necessitating confirmatory immunoassays .

Research Gaps and Future Directions

  • Standardization: Variability in assay sensitivity and epitope specificity (e.g., C-terminal vs. N-terminal gp210 regions) requires resolution .

  • Therapeutic Targets: Investigating gp210’s role in bile duct injury could yield novel therapies .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GB210 antibody; EMB3012 antibody; At5g40480 antibody; K21I16.30 antibody; Nuclear pore complex protein GP210 antibody; Nuclear pore membrane glycoprotein 210 antibody; Nucleoporin GP210 antibody; Protein EMBRYO DEFECTIVE 3012 antibody
Target Names
GB210
Uniprot No.

Target Background

Database Links

KEGG: ath:AT5G40480

STRING: 3702.AT5G40480.1

UniGene: At.55277

Protein Families
NUP210 family
Subcellular Location
Nucleus envelope. Nucleus membrane; Single-pass membrane protein. Nucleus, nuclear pore complex.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.